|
NF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.997090E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.890400E-02 |
| Normal-vs-Stage2 |
2.967500E-02 |
| Normal-vs-Stage3 |
1.85223999999984E-05 |
| Normal-vs-Stage4 |
3.84920000000566E-05 |
| Stage1-vs-Stage2 |
3.615400E-01 |
| Stage1-vs-Stage3 |
1.759590E-03 |
| Stage1-vs-Stage4 |
3.217600E-03 |
| Stage2-vs-Stage3 |
2.086800E-01 |
| Stage2-vs-Stage4 |
1.895760E-01 |
| Stage3-vs-Stage4 |
8.093200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.406900E-04 |
| Normal-vs-AfricanAmerican |
5.143800E-03 |
| Normal-vs-Asian |
6.684600E-01 |
| Caucasian-vs-AfricanAmerican |
5.342000E-01 |
| Caucasian-vs-Asian |
1.383990E-01 |
| AfricanAmerican-vs-Asian |
1.258820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.43829999999612E-05 |
| Normal-vs-Female |
2.521800E-02 |
| Male-vs-Female |
2.550500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.171900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.624340E-02 |
| Normal-vs-Age(61-80Yrs) |
9.54020000000222E-05 |
| Normal-vs-Age(81-100Yrs) |
2.579200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.226200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.540800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.128200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.225700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.375800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.776960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.886400E-01 |
| Normal-vs-Grade 2 |
5.768400E-02 |
| Normal-vs-Grade 3 |
2.26979999999877E-05 |
| Normal-vs-Grade 4 |
4.03649999980438E-07 |
| Grade 1-vs-Grade 2 |
1.354800E-01 |
| Grade 1-vs-Grade 3 |
4.359200E-03 |
| Grade 1-vs-Grade 4 |
7.755700E-04 |
| Grade 2-vs-Grade 3 |
1.897600E-03 |
| Grade 2-vs-Grade 4 |
3.393600E-04 |
| Grade 3-vs-Grade 4 |
1.107210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.014440E-01 |
| Normal-vs-ccB subtype |
9.211100E-04 |
| ccA subtype-vs-ccB subtype |
3.353700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.801200E-03 |
| Normal-vs-N1 |
4.135200E-01 |
| N0-vs-N1 |
8.214800E-01 |
|
|
